000			02498 a2200253 4500
999			_c112305 _d112305
003			BJBSDDR
005			20230411090105.0
007			ta
008			190319b2018 ny ||||| |||| 00| 0 eng d
020			_a9781524731656 _a9781524731663
040			_bspa _cBJBSDDR
041			_aeng
050	0	0	_aHD 9995 _bC315b 2018
082	0	0	_a338.7681761
100	1		_aCarreyrou, John
245	1	0	_aBad blood : _bsecrets and lies in a Silicon Valley startup / _cJohn Carreyrou
260			_aNew York : _bKnopf , _c2018
300			_a339 p. ; _c24 cm
505			_aA purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue.
520			_a "The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"
650		0	_92263 _aTheranos (Firma) _xHistoria.
942			_2lcc _cBK
946			_idpf